Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-12-11

Clinical Trial Update: MitoQ for the Treatment of Metabolic Dysfunction in Asthma [Phase 1]

View source ↗

Summary

Phase 1 results are posted for a study of MitoQ in metabolic dysfunction associated with asthma. The trial is sponsored by the University of Vermont and include…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MitoQ

Snippet

Sponsor: University of Vermont | Conditions: Asthma, Obesity | Phase 1 | Status: COMPLETED | Results posted: 2025-12-11